Please assess the completion status of the following clinical trial:

Trial Title: Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed locally advanced breast cancer~  * T3 inoperable, N0-N2~ * Any T, N2~ * T4, N0-N2~ * Inflammatory breast carcinoma~* Prior treatment with 4-6 courses of standard induction chemotherapy or active investigational regimens completed within the past 4 weeks~* Residual tumor size less than 5 cm~* No fixed axillary lymph nodes~* No multifocal or bilateral breast cancer~* No clinical suspicion of extensive ductal carcinoma in situ~* No unresolved skin edema~* No distant metastases (including ipsilateral supraclavicular node)~  * Positive bone scan allowed provided there are no bone metastases on x-ray~* Hormone receptor status:~  * Not specified~PATIENT CHARACTERISTICS:~Age:~* Any age~Sex:~* Female~Menopausal status:~* Not specified~Performance status:~* WHO 0-1~Life expectancy:~* Not specified~Hematopoietic:~* Neutrophil count at least 2,000/mm\^3~* Platelet count at least 100,000/mm\^3~Hepatic:~* Bilirubin less than 1.5 times normal~* SGOT and SGPT no greater than 2 times normal~* Alkaline phosphatase no greater than 2 times normal~Renal:~* Creatinine less than 1.5 times normal~Other:~* No other prior or concurrent malignancy except adequately treated squamous cell or basal cell skin cancer or adequately treated cone-biopsied carcinoma in situ of the cervix~* No serious underlying medical illness that would preclude study~* No psychiatric or addictive disorder that would preclude study~* No contraindication to study treatment~* Not pregnant~* Fertile patients must use effective barrier contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* See Disease Characteristics~Endocrine therapy:~* No concurrent hormonal replacement therapy~* No concurrent oral contraceptives~Radiotherapy:~* See Disease Characteristics~* No prior radiotherapy for breast cancer~Surgery:~* No prior surgery for breast cancer other than biopsy for diagnosis confirmation~Other:~* No other prior systemic therapy for breast cancer

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).